Advances in alcoholic liver disease: An update on alcoholic hepatitis
Authors:
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (42) , 11893-903
Abstract
Alcoholic hepatitis is a pro-inflammatory chronic liver disease that is associated with high short-term morbidity and mortality (25%-35% in one month) in the setting of chronic alcohol use. Histopathology is notable for micro- and macrovesicular steatosis, acute inflammation with neutrophil infiltration, hepatocellular necrosis, perivenular and perisinusoidal fibrosis, and Mallory hyaline bodies found in ballooned hepatocytes. Other findings include the characteristic eosinophilic fibrillar material (Mallory’s hyaline bodies) found in ballooned hepatocytes. The presence of focal intense lobular infiltration of neutrophils is what typically distinguishes alcoholic hepatitis from other forms of hepatitis, in which the inflammatory infiltrate is primarily composed of mononuclear cells. Management consists of a multidisciplinary approach including alcohol cessation, fluid and electrolyte correction, treatment of alcohol withdrawal, and pharmacological therapy based on the severity of the disease. Pharmacological treatment for severe alcoholic hepatitis, as defined by Maddrey’s discriminant factor ≥ 32, consists of either prednisolone or pentoxifylline for a period of four weeks. The body of evidence for corticosteroids has been greater than pentoxifylline, although there are higher risks of complications. Recently head-to-head trials between corticosteroids and pentoxifylline have been performed, which again suggests that corticosteroids should strongly be considered over pentoxifylline.Keywords
This publication has 99 references indexed in Scilit:
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed NalmefeneBiological Psychiatry, 2013
- Endotoxemia and gut barrier dysfunction in alcoholic liver disease†Hepatology, 2009
- A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic HepatitisGastroenterology, 2008
- Characterization of a novel arachidonic acid-derived neutrophil chemoattractantBiochemical and Biophysical Research Communications, 1992
- Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathyJournal of Hepatology, 1990
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excessJournal of Hepatology, 1987
- Short-Term and Long-Term Survival in Patients with Alcoholic Hepatitis Treated with Oxandrolone and PrednisoloneNew England Journal of Medicine, 1984
- Adrenocorticosteroid therapy in alcoholic hepatitisDigestive Diseases and Sciences, 1977
- HISTOLOGICAL CHANGES IN HUMAN LIVER BIOPSIES FROM CHRONIC ALCOHOLICSActa Pathologica Microbiologica Scandinavica Section A Pathology, 1972